Bioventix PLC (FRA:51B)
Germany flag Germany · Delayed Price · Currency is EUR
21.00
+0.60 (2.94%)
Last updated: Dec 5, 2025, 8:04 AM CET

Bioventix Company Description

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment.

The company also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results.

Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

Bioventix PLC
Country United Kingdom
Founded 2003
Industry Biological Products, Except Diagnostic Substances
Employees 12
CEO Peter Harrison

Contact Details

Address:
7 Romans Business Park
Farnham, GU9 7SX
United Kingdom
Phone 44 12 5272 8001
Website bioventix.com

Stock Details

Ticker Symbol 51B
Exchange Frankfurt Stock Exchange
Fiscal Year July - June
Reporting Currency GBP
SIC Code 2836

Key Executives

Name Position
Peter Harrison Chief Executive Officer
Bruce Edward Hiscock Chief Financial Officer